CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Methods Of Treating Pulmonary Arterial HypertensionACTELION PHARMACEUTICALSJun 3, 2025
Pharmaceutical Composition For The Treatment Of Pulmonary Arterial HypertensionACTELION PHARMACEUTICALSFeb 21, 2025
Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICADec 20, 2021
Controlled Release Pharmaceutical CompositionASTELLAS PHARMASep 29, 2021
Pharmaceutical Combinations Of An Angiotensin Receptor Antagonist And An Nep InhibitorNOVARTISApr 7, 2021
(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofAMGEN EUROPEOct 15, 2019

Top competitors of Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi

List of top competitors of Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi based on patent oppositions.